# Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms

> **NCT01300416** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 101 (actual)

## Conditions studied

- Kidney Transplantation
- GI Symptoms Severity

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01300416
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2016-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01300416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01300416, "Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01300416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*